Side effects of Berodual
When using Berodual®, as with any drug, certain side effects can occur, although these do not necessarily occur because each person tolerates drugs differently. If side effects occur, a doctor should be informed, depending on the severity of the symptoms. The occurrence of coughing is often reported after the use of Berodual®.
Occasionally patients complain of headaches, trembling, nervousness, dizziness, palpitations, a rise in blood pressure and an increased heart rate (tachycardia), as well as nausea, vomiting and dry mouth. In addition, the use of Berodual® can occasionally lead to inflammation in the throat area and voice formation disorders. Rarely does the use of Berodual® lead to allergic reactions with skin rashes, psychological changes, and a drop in the potassium level in the blood.
In rare cases, eye complaints are accompanied by heart complaints (angina pectoris, supraventricular tachycardia), lung constrictions (paradoxical bronchospasms) and muscular complaints are also rare. Furthermore, a lack of platelets, which are responsible for the clotting of the blood, is rarely reported (thrombocytopenia). Rare possible gastrointestinal complaints are: Very rarely there can also be an increase in blood sugar levels. – Increase in intraocular pressure
- Eye Pain
- Corneal swelling
- Feeling of fullness Völlegefu
- Constipation
- Diarrhoea
- Heartburn
Interactions of Berodual
Since the use of Berodual® may cause the potassium level in the blood to drop, any additional intake of potassium-lowering drugs (theophylline, corticosteroids, certain diuretics, digitalis) must be carefully weighed and monitored. The effect of Beroduals® can be enhanced by the simultaneous intake of other so-called beta-adrenergic sympathomimetics and other anticholinergics; strong side effect reactions are also possible with these intake combinations. The effect of Berodual® is attenuated by blood pressure lowering drugs such as beta-blockers.
Although no specific incompatibilities between Berodual® and alcohol are known to date, the principle should apply here, as with any drug, that the consumption of alcohol should be avoided as far as possible while taking drugs. However, since Berodual® is not expected to pose a particularly serious risk to the liver, moderate alcohol consumption is generally considered harmless and is therefore permitted. Berodual® even contains small amounts of alcohol itself.
Unfortunately, the data available on studies on the tolerance of Berodual® during pregnancy is very thin. Therefore, according to the current state of knowledge, a risk to mother and child cannot be ruled out, which is why the use of Berodual® during pregnancy is generally not recommended. In particularly severe cases of illness which cannot be controlled without Berodual®, an attempt at therapy in reduced doses may be made under certain circumstances after consulting the doctor. The same applies to breastfeeding: here too, it is not sufficiently clear whether the drug can be transmitted via breast milk and whether, in this case, it can harm the child. For this reason, Berodual® should not be taken during the breastfeeding period if at all possible, and only in absolutely exceptional cases should an attempt be made after consulting a doctor.
